Thermo Fisher Sees Broad-Based Customer Activity Strengthening in Q2
TMO sits 36% above its 52-week low of $405.15.
Summary
Thermo Fisher reported that customer activity across its end markets continued to strengthen during the second quarter. The company's Q2 results showed 10% revenue growth to $11.99B and 13% adjusted EPS growth, with profit and sales rising and beating quarterly estimates. This broad-based demand recovery builds on the company's long-term outlook for 7% organic growth and follows a strong Q1. With a $195B market cap, sustained momentum across life sciences, diagnostics, and analytical instruments could support further upward revisions to full-year guidance.
At the time of this announcement, TMO was trading at $550.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $195.6B. The 52-week trading range was $405.15 to $643.99. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.